As China’s leading health brand commercialization platform, Baheal Medical (stock code: 301015) spares no effort in building brand highways and providing upstream industrial enterprises with omni-channel solutions that improve their operational efficiency and promote the standardized development of the industry, by utilizing our three core capabilities in category insight-based brand operation, Baheal Data platform customer management, and long-term operation mechanisms. Over more than ten years of unremitting efforts, we have established a robust marketing network and stable cooperative relationships with hundreds of upstream companies, in addition to incubating multiple leading brands.
It is a leading brand of imported calcium that is easily absorbed, which has been leading in sales volume for five consecutive years. Over the past 20 years, we have been committed to providing global consumers with high-quality and safe calcium products made from high-quality calcium sources of the United States.
Containing dimeticone, it is a drug which can fully supplement pancreatic enzymes, effectively promote choleresis, quickly eliminate abdominal distension, and effectively relieve indigestion symptoms such as anepithymia, abdominal discomfort, early satiety, belching, fatty stool, chemical indigestion, etc.
As a category B drug, it has been included in the National Reimbursement Drug List (NRDL). With the level I medical evidence, it is the first anti-hepatic fibrosis therapeutic drug recommended in the Six Major Guidelines/Consensuses, and also the first Chinese patent drug for treatment of hepatopathy for which Phase II clinical trials have been completed in the United States upon approval by the FDA. Substantial clinical evidences show that Fuzhenghuayu has the efficacy of preventing and treating hepatic fibrosis and liver cirrhosis, and reducing the risk of liver cancer.
The new metformin is an osmotic pump-controlled release preparation, which can stabilize the blood concentration throughout the day due to the action of release at almost a constant speed. Although taken once a day, it has a long-lasting curative effect but less gastrointestinal side effects, which can reduce blood glucose stably.
Having lean quality, it can stably reduce blood pressure. Having passed the consistency evaluation, the high-quality Nifedipine Controlled-release Tablets are used for treatment of hypertension and coronary heart disease.
Nutrasumma is an American brand specialized in the development and production of natural, organic, high-potency dietary supplements.
Originated from an important invention made in a Japanese medical laboratory, the micro-needle eye mask applying the "transdermal drug delivery technology” enables the users to enjoy medical-grade care services at home. Medical evidences show that it is safe and effective, and users do not need to worry about trauma, pain, escharosis and reconstruction. With more than 40 patents, it has a high efficacy despite of simple ingredients, which can effectively relieve the symptoms such as dark circles, fine lines around the eyes, etc.
This cosmetic product is developed by Sato, a leading brand of medical skin care in Japan. It features the unique basal repair components, and the use of DDS drug slow-release osmosis technology, Sato’s exclusive ointment technology, and plant essence extraction and mixing technology. It enables the skin care from base, which can explore the potential of skin cells, and exude a healthy beauty from inside to outside.
TRANSINO is a comprehensive stain care brand owned by Daiichi Sankyo, a pharmaceutical group established over a century ago. TRANSINO focuses on the research of "Tranexamic Acid" with its effect in reducing melanin synthesis and dark spots in skin. Based its research on the validation of skin science, it offers multiple treatments to skin problems like dark spots, dry and rough skin problems, and helps to reproduce superior beauty.
Back to Top